{"disease":{"id":"revascularization","name":"revascularization"},"drugs":{"marketed":[{"drug_id":"fluvastatin-sodium","indication_name":"Reduce Risk of Coronary Revascularization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FLUVASTATIN SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"HMG-CoA reductase","drug_class":"","quality_score":60,"revenue":null,"mechanism":"Fluvastatin inhibits HMG-CoA reductase, reducing cholesterol synthesis."},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Trevo Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device and a Trevo Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":14,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07130968","title":"Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200000,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT04691037","title":"CCTA Improves Clinical Management of Stable Chest Pain","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Tianjin Chest Hospital","has_results":false},{"nct_id":"NCT02425345","title":"Women's Health Initiative Strong and Healthy Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":49331,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT03776266","title":"The Long-term Clinical Outcomes and Patterns of Transfusion in PCI Patients: Retrospective Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":48786,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT03788148","title":"Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion","phase":"","overall_status":"COMPLETED","enrollment_count":28322,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT06766084","title":"Is Total Arterial Revascularization Superior to Multiarterial Grafting in Coronary Artery Bypass Grafting","phase":"","overall_status":"COMPLETED","enrollment_count":7878,"lead_sponsor_name":"Technion, Israel Institute of Technology","has_results":false},{"nct_id":"NCT05284747","title":"EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6019,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT05416853","title":"Radial Versus Femoral Access For Carotid Artery Stenting","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"The First Affiliated Hospital of University of Science and Technology of China","has_results":false},{"nct_id":"NCT04837001","title":"Evaluation in STEMI Patients Using FDY-5301","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2351,"lead_sponsor_name":"Faraday Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT03256513","title":"The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2270,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT03229941","title":"Transfusion Trigger After Operations in High Cardiac Risk Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":1424,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT05532631","title":"Percutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With Left Ventricular Dysfunction (PROVERB)","phase":"NA","overall_status":"RECRUITING","enrollment_count":1040,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03491722","title":"Surviving a Decade or More After Coronary Revascularization in a Middle Eastern Population","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Jordan Collaborating Cardiology Group","has_results":false},{"nct_id":"NCT01881555","title":"Functional Testing Underlying Coronary Revascularisation","phase":"NA","overall_status":"COMPLETED","enrollment_count":941,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06546228","title":"Long Term Predictors of Acute Myocardial Infarction in Patients With Coronary Revascularization","phase":"","overall_status":"COMPLETED","enrollment_count":652,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Policlinico \"G. Martino\"","has_results":false},{"nct_id":"NCT05614180","title":"Chronic Total Occlusive Lesions CMR Study","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Lin Zhao","has_results":false},{"nct_id":"NCT06686121","title":"Improving Mobility After Revascularization in Peripheral Artery Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":386,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT05619068","title":"The Evolution and Prognosis of Moyamoya Disease","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05835167","title":"Complete Revascularization Via Inferior Part-sternotomy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":260,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT07314138","title":"Multivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-pump Coronary Artery Bypass Grafting","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Catharina Ziekenhuis Eindhoven","has_results":false},{"nct_id":"NCT05803759","title":"The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Institute for Atherosclerosis Research, Russia","has_results":false},{"nct_id":"NCT04683133","title":"The FAST OCT Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT06924593","title":"Study on the Trans-Carotid Artery Occlusion Shunt System","phase":"NA","overall_status":"RECRUITING","enrollment_count":162,"lead_sponsor_name":"Shenzhen Wecan Medical Technology Co.,Ltd","has_results":false},{"nct_id":"NCT06629701","title":"A Prospective Randomized Trial of External Vein Graft Support in Surgical Myocardial Revascularization","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":150,"lead_sponsor_name":"University Hospital Pilsen","has_results":false},{"nct_id":"NCT02317237","title":"\"GOLIATH\" - General Or Local Anaestesia in Intra Arterial THerapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT07212842","title":"Methylene Blue-Enhanced Ultrafiltration Improves Outcomes After Cardiopulmonary Bypass","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"University of Sao Paulo","has_results":false},{"nct_id":"NCT05306119","title":"Developing a Method of Rehabilitation for Patients After Myocardial Revascularization","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Gomel State Medical University","has_results":false},{"nct_id":"NCT05315349","title":"Retinal Microvascular Network and Coronary Revascularization Surgery at the Dijon University Hospital","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT04790656","title":"Interventional Effects on Myocardial Revascularization Post-surgical Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT07534319","title":"Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular Thrombectomy","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT03746132","title":"Oxygen for Vascular Incisional Healing","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Neogenix, LLC dba Ogenix","has_results":false},{"nct_id":"NCT05670028","title":"Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT05147025","title":"Evaluation of Retreatment of Failed Revasculatized Teeth by Revascularization","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT07460869","title":"Compare Between the Effect of CGF and PRF on Revascularization of Immature Roots of the Mandibular Permanent First Molar","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT04639856","title":"ICU Stay in Patients With Low Ejection Fraction Undergoing Cardiac Revascularization: Comparison of On-pump vs Off-pump Coronary Artery Bypass Grafting","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Armed Forces Institute of Cardiology, Pakistan","has_results":false},{"nct_id":"NCT07093632","title":"Medium-term Results of Lower Limb Arterial Bypass","phase":"","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04591938","title":"FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Joost Daemen","has_results":false},{"nct_id":"NCT05331547","title":"BioFreedom™ BA9™ Ultra","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT05168553","title":"Evaluation of Revascularization of Failed Endodontically Treated Mature Permanent Teeth","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT06347640","title":"Outcome of Pulp Revascularization of Necrotic Mature Permanent Teeth Using Platelet-rich Fibrin","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"King Abdullah University Hospital","has_results":false},{"nct_id":"NCT06520215","title":"Correlation Hand Grip Strength and Walking Distance in Elderly","phase":"","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Universitas Padjadjaran","has_results":false},{"nct_id":"NCT03713450","title":"Patient and Staff Safety During Aorto-iliac Revascularization Procedures Under Automated Fusion Imaging Guidance With Controls","phase":"NA","overall_status":"TERMINATED","enrollment_count":45,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT01270945","title":"Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT06963255","title":"Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07328646","title":"BEHAVIOR CHANGE INTERVENTION AFTER ENDOVASCULAR REVASCULARIZATION IN PAD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Muğla Sıtkı Koçman University","has_results":false},{"nct_id":"NCT05676957","title":"Reperfusion With Hypothermia in Acute Ischemic Stroke","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Liping Liu","has_results":false},{"nct_id":"NCT07514962","title":"Minimally Invasive Coronary Artery Bypass Supported by Cangrelor","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Cardiocentro Ticino","has_results":false},{"nct_id":"NCT06630156","title":"The Present Study Was Conducted to Evaluate Bioceramic Root Repair Material Versus Bio MTA in Revascularization of Immature Young Permenant Teeth.","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Al-Azhar University","has_results":false},{"nct_id":"NCT07258888","title":"Pulp Transplantation in Necrotic Mature Teeth With Periapical Radiolucency","phase":"NA","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Kahramanmaras Sutcu Imam University","has_results":false},{"nct_id":"NCT03788369","title":"Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization","phase":"","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Seung-Jung Park","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}